15:59 Dec 20
Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lyka Labs Ltd.
Industry Pharmaceuticals
15:59 Dec 20
Quality
43/100
Medium Financial Strength
Valuation
19/100
Expensive Valuation
Technical
60/100
Technically Moderately Bullish
Strength
6
Weakness
6
Opportunity
0
Threats
0
534.42
Market Cap (Cr)
143.08
PE Ratio
5.40
Price to Book Ratio
41.94
RSI
-2.23 %
Net Profit Margin
Download Our App On:
